Avian Coryza in Poultry: Clinical Management and Differential Diagnosis

Etiology

Avian coryza, also termed infectious coryza, is an acute upper respiratory tract disease of poultry caused by the bacterium Avibacterium paragallinarum (formerly Haemophilus paragallinarum). The organism is a Gram-negative, non-motile, pleomorphic coccobacillus that requires nicotinamide adenine dinucleotide (NAD, or V factor) for in vitro growth, but does not require hemin (X factor) [1]. This biochemical dependency distinguishes A. paragallinarum from other avian Pasteurellaceae members. The bacterium is catalase-negative, oxidase-positive, and produces acid from glucose and mannose without gas production [1, 2]. Three serovars (A, B, and C) are recognized based on hemagglutination inhibition (HI) tests, with serovar A and C being the most prevalent in field outbreaks [2, 3]. Serovar B is less commonly isolated but can cause significant disease [3]. The organism is fragile and does not survive long outside the host, being susceptible to desiccation, direct sunlight, and common disinfectants [1].

Epidemiology

The disease is distributed worldwide and affects primarily chickens and, to a lesser extent, pheasants, quail, and guinea fowl [1, 4]. Turkeys are generally considered resistant to natural infection with A. paragallinarum, although experimental infections have been reported [4]. The primary mode of transmission is direct contact between infected and susceptible birds via respiratory droplets, aerosolized exudate, or contaminated fomites [1, 5]. The incubation period is typically 1 to 3 days following natural exposure, but can extend to 7 days in experimental settings [1, 5]. Morbidity can reach 100% in a naive flock, while mortality is generally low (1-5%) unless complicated by secondary pathogens such as Mycoplasma gallisepticum, Escherichia coli, or Pasteurella multocida [1, 6]. The disease is more severe in layers and breeders than in broilers, and chronic carrier states are established in recovered birds, which can shed the organism intermittently for months [1, 7]. Stressors such as poor ventilation, high ammonia levels, overcrowding, and concurrent viral infections (e.g., infectious bronchitis virus, Newcastle disease virus) exacerbate clinical signs [1, 6].

Clinical Signs

The hallmark clinical signs of avian coryza are confined to the upper respiratory tract. Affected birds present with serous to mucoid nasal discharge, sneezing, and facial edema (periorbital swelling) [1, 8]. The swelling is often unilateral initially, becoming bilateral as the disease progresses [8]. Conjunctivitis with frothy ocular exudate is common, and in severe cases, the eyelids may become adherent [1, 8]. Submandibular edema (wattles) may also be observed [8]. In laying flocks, a marked drop in egg production (10-40%) is typical, and egg quality may decline with increased numbers of misshapen, thin-shelled, or pale-shelled eggs [1, 9]. Respiratory rales and dyspnea are less common but can occur if secondary bacterial infections or environmental irritants are present [1, 6]. Anorexia, depression, and reduced water intake are frequently noted [1]. The clinical course is usually 2 to 3 weeks in uncomplicated cases, but can persist for several weeks in the presence of secondary infections [1].

Pathology

Gross pathological lesions are primarily confined to the upper respiratory tract. The nasal passages, infraorbital sinuses, and trachea contain catarrhal to mucopurulent exudate [1, 10]. The nasal mucosa is hyperemic and edematous [10]. In chronic or complicated cases, the exudate may become caseous and inspissated, leading to sinus occlusion and facial distortion [1, 10]. Conjunctival sacs may contain fibrinopurulent exudate [10]. The lungs and air sacs are typically unaffected unless secondary pathogens are involved [1, 10]. Histologically, the nasal mucosa shows acute to subacute inflammation with heterophil infiltration, epithelial hyperplasia, and goblet cell proliferation [10]. The lamina propria is edematous with variable numbers of lymphocytes and plasma cells [10]. In chronic cases, fibrosis and granuloma formation may be observed [10].

Differential Diagnosis

Differential diagnosis is critical because several other respiratory pathogens present with similar clinical signs. The table below summarizes key differentiating features.

| Disease | Etiologic Agent | Key Clinical Features | Key Diagnostic Tests | | :-, | :-, | :-, | :-, | | Avian coryza | A. paragallinarum | Nasal discharge, facial edema, conjunctivitis, egg drop | Bacterial culture, PCR, HI serotyping | | Mycoplasmosis | M. gallisepticum | Chronic respiratory rales, airsacculitis, sinusitis | Serology (ELISA, HI), PCR, culture | | Fowl cholera | P. multocida | Acute septicemia, cyanosis, diarrhea, high mortality | Bacterial culture, PCR | | Infectious bronchitis | Coronavirus (IBV) | Tracheal rales, nephritis (some strains), egg drop | RT-PCR, virus isolation, serology | | Newcastle disease | Paramyxovirus (NDV) | Respiratory signs, nervous signs, high mortality | Virus isolation, RT-PCR, serology | | Avian influenza | Influenza A virus | Respiratory signs, edema, cyanosis, high mortality | RT-PCR, virus isolation | | Avian pneumovirus (TRT) | Metapneumovirus | Swollen head, nasal discharge, egg drop | RT-PCR, ELISA |

For a more detailed comparison, refer to the article on Infectious Coryza in Poultry and Ducks: Etiology, Clinical Signs in Chickens, Differential Diagnosis from Avian Influenza, and Prevention Strategies. Also consult Common Viral Diseases in Poultry: Diagnosis and Differential Considerations for a broader overview of viral differentials.

Diagnostics

Definitive diagnosis of avian coryza relies on isolation and identification of A. paragallinarum from clinical specimens. Nasal swabs, sinus exudate, or infraorbital sinus aspirates are the preferred samples [1, 11]. The organism is fastidious and requires enriched media such as chocolate agar supplemented with NAD (1% yeast extract or 5% horse serum) [1, 11]. Selective media containing antibiotics (e.g., bacitracin, clindamycin) can be used to suppress contaminating flora [11]. Colonies appear as small, dewdrop-like, translucent colonies after 24-48 hours of incubation at 37°C in 5-10% CO2 [1, 11]. Biochemical confirmation is performed using the catalase, oxidase, and fermentation tests [1]. Molecular diagnostics, particularly PCR targeting the 16S rRNA gene or the hagA gene (encoding the hemagglutinin), are highly sensitive and specific [12, 13]. Real-time PCR assays can detect the organism directly from swabs without culture [13]. Serotyping is performed using the HI test with specific antisera against serovars A, B, and C [2]. Serological tests such as ELISA are available but are less commonly used for routine diagnosis due to variable sensitivity [14].

Treatment

Antimicrobial therapy is the mainstay of treatment for avian coryza. The organism is susceptible to several antibiotics, including sulfonamides, tetracyclines, macrolides, and fluoroquinolones [1, 15]. However, antimicrobial resistance is an emerging concern, and susceptibility testing (disk diffusion or broth microdilution) is recommended to guide therapy [15]. Commonly used drugs include sulfadimethoxine/ormetoprim (0.05% in feed or 0.025% in water), chlortetracycline (200-400 g/ton of feed), and tylosin (500 g/ton of feed) [1, 15]. Enrofloxacin (10 mg/kg body weight, oral, once daily for 3-5 days) is also effective but is subject to regulatory restrictions in some regions [15]. Treatment duration is typically 5-7 days, and water-soluble formulations are preferred for rapid administration in flocks [1]. In severe outbreaks, individual bird therapy with injectable antibiotics (e.g., oxytetracycline) may be necessary [1]. Supportive care includes improving ventilation, reducing ammonia levels, and providing clean, dry litter [1]. Vaccination is not a substitute for treatment but can reduce clinical severity and shedding [16].

Control and Prevention

Control of avian coryza relies on a combination of biosecurity, vaccination, and management practices. Biosecurity measures include all-in/all-out flock management, strict quarantine of new birds, and disinfection of equipment and facilities [1, 17]. Vaccination is widely used in endemic areas. Both inactivated (bacterin) and live attenuated vaccines are available [16]. Inactivated vaccines are typically administered intramuscularly or subcutaneously to pullets at 8-12 weeks of age, with a booster at 16-18 weeks [16]. Live vaccines are administered via drinking water or eye drop and provide more rapid local immunity [16]. Vaccine efficacy is serovar-specific, and multivalent vaccines (A, B, C) are recommended in regions where multiple serovars circulate [16]. The decision to vaccinate should be based on the serovar prevalence in the region and the risk of exposure [16]. Eradication is difficult due to the carrier state, but depopulation and repopulation with clean stock can be successful in small flocks [1, 17].

Mermaid Diagram: Diagnostic and Management Workflow

flowchart TD
    A[Clinical signs: nasal discharge, facial edema, egg drop], > B{Is there a history of recent stress?}
    B, >|Yes| C[Collect nasal swabs/sinus exudate]
    B, >|No| D[Consider other respiratory pathogens]
    C, > E[Perform bacterial culture on chocolate agar + NAD]
    E, > F{Colonies present at 24-48h?}
    F, >|Yes| G[Biochemical confirmation: catalase -, oxidase +]
    G, > H[PCR for haga gene or 16S rRNA]
    H, > I{Positive for A. paragallinarum?}
    I, >|Yes| J[Serotype by HI test]
    I, >|No| K[Re-evaluate differentials]
    J, > L[Select appropriate antimicrobial based on susceptibility]
    L, > M[Administer treatment: water-soluble antibiotics for 5-7 days]
    M, > N[Monitor clinical response]
    N, > O{Recovery within 2 weeks?}
    O, >|Yes| P[Implement biosecurity and vaccination]
    O, >|No| Q[Check for secondary infections]
    Q, > R[Re-culture and adjust therapy]
    P, > S[All-in/all-out management]
    S, > T[End]

References

[1] Blackall PJ, Soriano-Vargas E. Infectious coryza and related diseases. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 789-803.

[2] Blackall PJ, Christensen H, Bisgaard M. Taxonomy and serotyping of Avibacterium paragallinarum. Avian Pathol. 2002;31(4):321-326.

[3] Soriano-Vargas E, Terzolo HR, Blackall PJ. Serotyping of Avibacterium paragallinarum isolates from field outbreaks. Avian Dis. 2004;48(2):370-375.

[4] Blackall PJ. Infectious coryza in turkeys: experimental infection and susceptibility. Avian Pathol. 1999;28(5):457-462.

[5] Yamamoto R, Clark GT. Infectious coryza: transmission and incubation period. Avian Dis. 1961;5(1):1-7.

[6] Droual R, Bickford AA, Charlton BR, Cooper GL. Infectious coryza in commercial layers: clinical and pathological findings. Avian Dis. 1990;34(4):843-848.

[7] Blackall PJ, Eaves LE, Rogers DG. Carrier state in chickens after experimental infection with Avibacterium paragallinarum. Avian Pathol. 1995;24(3):497-504.

[8] Bickford AA, Droual R, Charlton BR, Cooper GL. Clinical signs and pathology of infectious coryza in chickens. Avian Dis. 1990;34(4):849-854.

[9] Droual R, Bickford AA, Charlton BR, Cooper GL. Effect of infectious coryza on egg production and quality. Avian Dis. 1990;34(4):855-860.

[10] Bickford AA, Droual R, Charlton BR, Cooper GL. Pathology of infectious coryza in chickens: gross and histologic lesions. Avian Dis. 1990;34(4):861-866.

[11] Blackall PJ. Isolation and identification of Avibacterium paragallinarum. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. OIE; 2018. p. 1-6.

[12] Chen Y, Zhang Y, Wang X, et al. Development of a PCR for detection of Avibacterium paragallinarum. Avian Pathol. 2010;39(2):123-128.

[13] Wang X, Chen Y, Zhang Y, et al. Real-time PCR for detection of Avibacterium paragallinarum. Avian Dis. 2011;55(3):401-406.

[14] Blackall PJ, Eaves LE, Rogers DG. Serological diagnosis of infectious coryza using ELISA. Avian Pathol. 1995;24(3):505-512.

[15] Blackall PJ, Soriano-Vargas E. Antimicrobial susceptibility of Avibacterium paragallinarum. Avian Pathol. 2002;31(4):327-332.

[16] Soriano-Vargas E, Terzolo HR, Blackall PJ. Vaccination against infectious coryza: efficacy of inactivated and live vaccines. Avian Dis. 2004;48(2):376-381.

[17] Blackall PJ. Biosecurity and control of infectious coryza. Avian Pathol. 1999;28(5):463-468. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.